FDA Delay Forces Kezar Life Sciences to Close Its Doors
A four-month FDA meeting cancellation proved fatal for Kezar Life Sciences, highlighting how regulatory delays can devastate small biotech companies.
Drug Development
2 articles tagged "Drug Development"
FDA Delays Force Kezar Life Sciences to Shut Down
Kezar Life Sciences is winding down after FDA meeting cancellations disrupted its autoimmune hepatitis drug program, driving investors to withdraw funding.